ストックスクリーナーアプリを入手
26.17
5.06%
1.26
前日終値:
$24.91
開ける：
$26.45
24時間の取引高:
414.62K
Relative Volume:
1.32
時価総額：
$1.53B
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+8.72%
1か月 パフォーマンス:
-2.31%
6か月 パフォーマンス:
+39.54%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$24.32
$27.18
1週間の範囲:
$23.46
$27.18
52週間の値動き範囲:
$13.25
$30.00
Kestra Medical Technologies Ltd Stock (KMTS) Company Profile
名前
Kestra Medical Technologies Ltd
セクター
電話
(425) 279-8002
住所
3933 LAKE WASHINGTON BLVD NE, KIRKLAND
KMTS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
KMTS
Kestra Medical Technologies Ltd
|
26.17 | 1.45B | 0 | 0 | 0 | 0.00 |
|
ISRG
Intuitive Surgical Inc
|
542.32 | 194.04B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
200.89 | 57.21B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
78.80 | 38.69B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
252.27 | 36.84B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
267.56 | 19.61B | 2.96B | 487.70M | 344.00M | 6.6758 |
Kestra Medical Technologies Ltd Stock (KMTS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-18 | 開始されました | BTIG Research | Buy |
| 2025-03-31 | 開始されました | BofA Securities | Buy |
| 2025-03-31 | 開始されました | Goldman | Neutral |
| 2025-03-31 | 開始されました | Piper Sandler | Overweight |
| 2025-03-31 | 開始されました | Stifel | Buy |
| 2025-03-31 | 開始されました | Wells Fargo | Overweight |
| 2025-03-31 | 開始されました | Wolfe Research | Outperform |
すべてを表示
Kestra Medical Technologies Ltd (KMTS) 最新ニュース
Kestra Medical Technologies’ revenue up 53% to USD 22.6M in Q2 FY26 - Medical Buyer
Kestra Medical Technologies, Ltd. $KMTS Position Increased by Eventide Asset Management LLC - MarketBeat
Kestra Medical Technologies Reports Strong Earnings Growth - TipRanks
Kestra Medical Technologies stock price target raised by Stifel to $30 - Investing.com Australia
Kestra Medical Technologies stock price target raised to $30 from $27 at Piper Sandler - Investing.com India
Kestra Medical price target raised to $30 from $27 at Piper Sandler - TipRanks
Kestra Medical Technologies: Strong Financial Performance and Market Leadership Drive Buy Rating - TipRanks
Kestra raises FY26 revenue guidance to $91M while targeting 70%+ gross margins with ASSURE system expansion - MSN
Is Kestra Medical Technologies Ltd a good long term investmentSector Performance Drivers & High Return Trading Strategies - earlytimes.in
Kestra Medical Technologies Ltd (KMTS) Q2 2026 Earnings Call Highlights: Revenue Surge and ... By GuruFocus - Investing.com Canada
Earnings call transcript: Kestra Medical Technologies Q2 2025 shows strong revenue growth - Investing.com Australia
Kestra Medical raises FY26 revenue view to $91M from $88M, consensus $88.02M - TipRanks
Kestra Medical (KMTS) Q2 2026 Earnings Transcript - The Globe and Mail
Kestra Medical Technologies Q2 2026 Earnings Call Transcript - MarketBeat
KESTRA MEDICAL TECHNOLOGIES, LTD. SEC 10-Q Report - TradingView
Kestra Medical reports Q2 EPS (64c), consensus (57c) - TipRanks
Kestra Medical Fiscal Q2 Loss Narrows, Revenue Rises; Fiscal 2026 Revenue Outlook Lifted - marketscreener.com
Kestra Medical Technologies plunges 11% as quarterly loss exceeds estimates - Investing.com
Kestra Medical Technologies Reports Second Quarter Fiscal 2026 Financial Results - TradingView
Earnings Flash (KMTS) Kestra Medical Technologies, Ltd. Reports Q2 Revenue $22.6M, vs. FactSet Est of $20.7M - marketscreener.com
Kestra Medical Technologies announces public offering of common shares - MSN
A&O Shearman advised on Kestra Medical Technologies upsized USD158.7 million follow-on equity offering - A&O Shearman
Earnings To Watch: Kestra Medical Technologies Ltd (KMTS) Reports Q2 2025 Result - GuruFocus
Archimedes Vascular Announces Close of Series A Financing led by Sherpa Healthcare Partners and Appoints Raymond W. Cohen as Chairman of its Board of Directors - Quantisnow
Kestra Medical Technologies, Ltd. $KMTS Shares Sold by Omega Fund Management LLC - MarketBeat
Brown Advisory Inc. Increases Position in Kestra Medical Technologies, Ltd. $KMTS - Defense World
Assessing Kestra Medical Technologies (KMTS) Valuation After Its Recent Share Price Pullback - Yahoo Finance
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Kestra Medical prices upsized $138M offering - MSN
Kestra Medical Raises $148.4 Million in Public Offering - TipRanks
Kestra Medical Technologies (NASDAQ:KMTS) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
Can Kestra Medical Technologies Ltd. stock withstand economic slowdown2025 Sector Review & Safe Entry Point Alerts - Newser
Kestra Medical Technologies (KMTS): Assessing a 20x Sales Valuation After a Recent Double-Digit Daily Gain - simplywall.st
Will Kestra Medical Technologies Ltd. stock see PE expansionEarnings Miss & Consistent Profit Trading Strategies - Newser
Form 424B4 KESTRA MEDICAL TECHNOLOG - StreetInsider
Kestra Medical Technologies (NASDAQ:KMTS) Shares Gap UpStill a Buy? - MarketBeat
Kestra Medical Technologies (Nasdaq: KMTS) sets Dec. 11 call to discuss Q2 fiscal 2026 results - Stock Titan
Kestra Medical Technologies, Ltd. to Report Second Quarter Fiscal 2026 Financial Results - marketscreener.com
Kestra Medical Technologies Prices Upsized Offering of 6 Million Shares - marketscreener.com
Kestra Medical Technologies prices upsized public offering at $23 per share By Investing.com - Investing.com South Africa
Kestra Medical Technologies prices upsized public offering at $23 per share - Investing.com Australia
KMTS FinancialsIncome Statement - Quiver Quantitative
Kestra Medical says co prices upsized primary public offering of 6 million shares at $23 per share - marketscreener.com
Kestra Medical Technologies, Ltd. Announces Pricing of Upsized Primary Public Offering of Common Shares - MarketScreener
Kestra Medical Technologies (NASDAQ:KMTS) Shares Gap DownShould You Sell? - MarketBeat
Kestra Medical Technologies sees Q2 revenue between $22.2M and $22.6M - MSN
Kestra Medical Technologies announces underwritten public offering - Medical Buyer
Kestra Medical announces public offering of 5.5 million shares By Investing.com - Investing.com Canada
Kestra Medical Technologies, Ltd. Provides Revenue Guidance for the Second Quarter Fiscal 2026 - marketscreener.com
Kestra Medical Technologies reports preliminary second quarter fiscal 2026 financial results - marketscreener.com
Kestra Medical Technologies Ltd (KMTS) 財務データ
Kestra Medical Technologies Ltd (KMTS) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
1.32%
0.04%
大文字化:
|
ボリューム (24 時間):